Disease / condition

Chronic Kidney Disease 5D,Heart Failure,Heart Failure NYHA Class I,Heart Failure NYHA Class II clinical trials

Free access to 1 studies·1+ countries·Updated daily

Total trials

Countries

Sponsors

N/A

Recruiting

By phase

N/A1

By status

Completed1

Top countries

Russian Federation1

Top sponsors

Moscow Regional Re...1

Recent trials

Latest clinical trials for Chronic Kidney Disease 5D,Heart Failure,Heart Failure NYHA Class I,Heart Failure NYHA Class II

NCT06394986Completed

Cardio-fistular Recirculation in Patients With Chronic Heart Failure and Preserved Left Ventricle Ejection Fraction

Moscow Regional Research and C...Russian Federation

View all 1 trials →

About this record

Access comprehensive clinical trial information for Chronic Kidney Disease 5D,Heart Failure,Heart Failure NYHA Class I,Heart Failure NYHA Class II through Pure Global AI's free database. This collection includes 1 clinical trials across multiple phases including N/A.

Research for Chronic Kidney Disease 5D,Heart Failure,Heart Failure NYHA Class I,Heart Failure NYHA Class II is being conducted in Russian Federation and more. Leading sponsors include Moscow Regional Research and Clinical Institute (MONIKI). Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 1 clinical trials studying Chronic Kidney Disease 5D,Heart Failure,Heart Failure NYHA Class I,Heart Failure NYHA Class II, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 1+ countries.

Top research sponsors include Moscow Regional Research and Clinical Institute (MONIKI), among others.